-
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants
Friday, February 17, 2023 - 2:44pm | 310Numinus Wellness (OTCQX: NUMIF) expanded its clinical research capabilities into Phoenix, where the psychedelic-assisted therapy provider currently operates mental health clinics. This is Numinus' third U.S.-based clinical trial research facility and fifth research site overall. It is set...
-
Exclusive: Novamind CEO On Going Public: 'We're Focused On Treating People Today'
Tuesday, January 5, 2021 - 2:27pm | 1121Novamind became the latest psychedelics company to go public through a reverse take-over with Hinterland Metals Inc. The company debuted in the Canadian Securities Exchange on Tuesday under the symbol "NM." In late November, Novamind closed a private placement for CA$10 million ($7.8...
-
Uncertainty Around Iqvia's Near-Term Earnings Path Is Clearing, Goldman Sachs Says In Upgrade
Friday, April 13, 2018 - 2:05pm | 443In a preview of the first-quarter results of contract research organizations,Goldman Sachs said the group remains attractive with a healthy fundamental backdrop and no material signs of a trend reversal in 2018. The firm also turned bullish on Iqvia Holdings Inc (NYSE: IQV). The Analyst...
-
INC Research Confirms Completion Of Merger With InVentiv Health
Tuesday, August 1, 2017 - 10:46am | 452INC Research Holdings Inc (NASDAQ: INCR) confirmed Tuesday its merger with inVentiv Health, Inc. has closed. The former is a global contract research organization that focuses on phase 1 through 4 clinical development services for the biopharmaceutical and medical device industries, while the...